What is Graft-Versus-Host Disease (GVHD) and why does it happen?
MDS experts, Dr Alan List and Dr David Sallman, provide an overview of graft-versus-host disease (GVHD), which might happen after an allogeneic transplant (a transplant that uses stem cells from a donor). In GVHD, the donor cells that make up your new immune system see your body’s cells as foreign and start to attack them. They also discuss acute GVHD and chronic GVHD, as well as medications to prevent or treat the condition.
Share with family and friends:
Click here to take our Myelodysplastic Syndromes (MDS) SURVEY Your feedback is important to us! We will use your feedback to develop future areas of content about MDS which will help other patients, caregivers and families.
This educational activity has been developed by
the Myelodysplastic Syndromes Foundation, Inc and Mechanisms in Medicine Inc.
This activity is supported by charitable grants from Celgene Corporation, Jazz Pharmaceuticals, Novartis, and Takeda Oncology.
This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their health care professionals for optimal outcomes.